Hiring in life sciences? Share your open positions with our professional community. Read more Close

Advertisement

Community-Based Accompaniment for Adolescents and Young Adults Transitioning into Adult HIV Care: Protocol of a Randomized Control Trial Evaluating the "PASEO" Intervention in Urban Peru.

Created on 23 Oct 2026

Authors

Molly F Franke, Renato Errea, Alyson Nunez, Milagros Wong, Hugo Sánchez, Carmen C Contreras, Jerome T Galea, Erika Gonzales, Isabel Ccota, Cristina Chávez, Alicia Ramos, Karen Finnegan, Diana Mejía, Jimena Ruiz-Cardenas, Grecia Herrera, Nicole Ocasio-Martinez, Letizia Trevisi, Martha Vibbert, Sonya Shin, Leonid Lecca

Published in

Behavioral medicine (Washington, D.C.). Volume 52. Issue 3-4. Pages 348-361. Epub Oct 21, 2026.

Abstract

We describe a randomized controlled trial evaluating a nine-month community-based accompaniment intervention (PASEO) to improve HIV outcomes and well-being among adolescents and young adults living with HIV (AYALWH) entering adult-centered HIV care in Lima, Peru. Participants (ages 14-23) are individually randomized (1:1) to PASEO or a modestly enhanced standard of care, with randomization stratified by health facility and caregiver support. The PASEO intervention aims to build health-related skills, enhance knowledge, promote psychosocial adjustment, and reduce logistical, administrative, and structural barriers to care and adherence. Intervention participants are assigned a health promoter who accompanies them throughout their transition to adult HIV care and coordinates their participation in organized intervention activities. Key elements of PASEO include health system navigation, including accompaniment to appointments and support with administrative procedures; regular in-person visits to foster independent health care management and goal setting, provide social support, and address needs in the home and social environment; individualized adherence support; a low-intensity psychological intervention; peer support groups; and education sessions. Each participant is followed for 24 months. The primary outcome is the cumulative incidence of unsuccessful transition (death, loss to follow-up, or unsuppressed viral load >200 copies/mL after six months of ART) at 12 and 24 months. Secondary outcomes include additional HIV-related indicators (e.g., CD4 count, adherence, clinic attendance) and measures of well-being (e.g., social support, self-efficacy, connectedness, transition readiness, stigma, condomless sex, and depression). Participants who experience the primary outcome are invited to receive intervention services.

PMID:
42904429
Bibliographic data and abstract were imported from PubMed on 23 Oct 2026.

Read full publication at:
Please sign in to see all details.

Advertisement

Stats

  • Community rating n/a 0 votes
  • Reviewers' rating n/a 0 votes
  • Your rating

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

  • Recommendations n/a n/a positive of 0 vote(s)
  • Views 19
  • Comments 0

Recommended by

  • No recommendations yet.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.

Advertisement